Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study

Background: Angiotensin Converting Enzyme inhibitors (ACEis) and beta-blockers (BB) are suggested to prevent and treat trastuzumab-related cardiac toxicity. We performed a prospective clinical trial in women experiencing mild cardiac toxicity (MCT) while on adjuvant treatment with trastuzumab. Metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Geuna, Elena, Lombardi, Pasquale, Martinello, Rossella, Garino, Davide, Bonzano, Alessandro, Galizia, Danilo, Nuzzo, Annamaria, Berchialla, Paola, Becco, Paolo, Mangioni, Monica, De Zarlo, Lorena, Montemurro, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072182/
https://www.ncbi.nlm.nih.gov/pubmed/32023877
http://dx.doi.org/10.3390/cancers12020327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072182/
https://www.ncbi.nlm.nih.gov/pubmed/32023877
http://dx.doi.org/10.3390/cancers12020327

Ejemplares similares